Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET (avatrombopag)
Dova Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET (avatrombopag) for the treatment of…
Read More...
Read More...
